SEC CIK 1131399
GLAXOSMITHKLINE PLC
Reported ownership across 30 companies, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| HGSIview stock → | 158,660,878 | 2012-07-30 |
| LYELview stock → | 30,253,189 | 2021-06-21 |
| WVEview stock → | 18,245,691 | 2025-12-11 |
| ORTXview stock → | 12,455,252 | 2020-01-01 |
| SPROview stock → | 9,190,606 | 2022-11-07 |
| ROBP.OBview stock → | 7,456,899 | 2007-03-12 |
| FOLDview stock → | 6,866,244 | 2010-11-12 |
| PGNYview stock → | 6,238,244 | 2020-05-20 |
| CRXAview stock → | 5,002,019 | 2005-04-29 |
| RGDXview stock → | 5,000,000 | 2012-09-13 |
| GNCAview stock → | 4,626,389 | 2020-07-24 |
| EPIXview stock → | 4,266,795 | 2006-12-18 |
| TBIOview stock → | 3,697,912 | 2018-07-02 |
| NKTXview stock → | 3,150,732 | 2020-07-14 |
| PRNBview stock → | 2,982,855 | 2019-10-18 |
| CRSPview stock → | 2,942,560 | 2016-10-24 |
| MORFview stock → | 2,633,772 | 2019-07-01 |
| TPTXview stock → | 2,253,660 | 2020-05-21 |
| PANDview stock → | 2,248,304 | 2020-07-21 |
| BCYCview stock → | 1,910,531 | 2020-07-15 |
| FULCview stock → | 1,785,714 | 2019-07-22 |
| ANACview stock → | 1,771,374 | 2010-11-23 |
| DBTXview stock → | 1,183,663 | 2021-02-17 |
| CVRXview stock → | 1,007,583 | 2021-07-02 |
| LQDAview stock → | 624,422 | 2018-07-30 |
| CCXIview stock → | 0 | 2018-10-16 |
| DGXview stock → | 0 | 2011-01-31 |
| INVAview stock → | 0 | 2021-05-20 |
| TBPHview stock → | 0 | 2022-09-16 |
| THRXview stock → | 0 | 2004-10-04 |
Position History — PRNB
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — PRNB
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2019-10-18 | Open-market buy | 357,142 | $28.00 | 2,982,855 |
| 2019-06-11 | Grant / award (derivative) | 10,240 | $0.00 | 10,240 |
| 2018-09-18 | Conversion (derivative) | 1,521,895 | $0.00 | 0 |
| 2018-09-18 | Conversion (derivative) | 4,942,070 | $0.00 | 0 |
| 2018-09-18 | Conversion (derivative) | 2,367,424 | $0.00 | 0 |
| 2018-09-18 | Conversion (derivative) | 2,840,909 | $0.00 | 0 |
| 2018-09-18 | Conversion (derivative) | 9,726,783 | $0.00 | 0 |
| 2018-09-18 | Open-market buy | 270,000 | $17.00 | 2,625,713 |
| 2018-09-18 | Conversion | 167,537 | — | 2,355,713 |
| 2018-09-18 | Conversion | 544,047 | — | 2,188,176 |
| 2018-09-18 | Conversion | 260,617 | — | 1,644,129 |
| 2018-09-18 | Conversion | 312,741 | — | 1,383,512 |
| 2018-09-18 | Conversion | 1,070,771 | — | 1,070,771 |
| 2018-09-13 | Grant / award (derivative) | 20,475 | $0.00 | 20,475 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.